DHL Supply Chain’s Life Sciences and Healthcare (LSHC) sector is investing upwards of $400 million to expand its pharmaceutical and medical device distribution network footprint by 27 percent this year – nearly three million additional square feet.   With the ultimate goal of bringing critical healthcare products closer to trade partners and patients, DHL Supply Chain’s new investment includes six new U.S. sites by the end of 2022. The investment includes costs to invest in new buildings and t...